MassDevice.com +3 | The top 3 med-tech stories for February 7, 2013

February 7, 2013 by MassDevice staff

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

3. Diabetes: Insulet and Dexcom call it quits on development agreement

Insulet and Dexcom decide not to pursue a joint development agreement to integrate Dexcom's continuous glucose monitoring technology with Insulet's insulin-infusing OmniPod.

Read more

Sign up to get our free newsletters delivered straight to your inbox

2. Losses soar, shares plummet for Accuray

Accuray's fiscal 2nd quarter sales plunge and its losses gape wider, sending share prices down almost 10% today.

Comments